Data / Research funding / California / Chromologic, LLC
Chromologic, LLC: 14 NIH awards ($16.3M), fiscal years 2021 to 2026
Chromologic, LLC in Monrovia, CA is funded under 14 NIH awards ($16.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- D9EVNTKKWLF3
- State
- California
Awards
14 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,879,349 | July 1, 2023 | June 30, 2026 | NGUYEN, THERESA | reporter.nih.gov |
| Development of second-generation probiotics as radiation mitigators | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,709,458 | March 16, 2021 | March 15, 2025 | ROGERS, CLAUDE | reporter.nih.gov |
| NGS based metagenomic screening of ocular infections | NIH | National Eye Institute | 2024 to 2025 | $1,701,925 | June 1, 2022 | August 31, 2027 | KYUBWA, ESPOIR | reporter.nih.gov |
| CRISPR-based Assay for Portable Tropical Infection Diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,499,763 | September 15, 2025 | September 14, 2028 | ZHUKOV, DMITRIY | reporter.nih.gov |
| Mobile Health Point-of-Care Diagnostics for Malaria | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,498,121 | July 19, 2021 | July 18, 2024 | PRICE, RHODA | reporter.nih.gov |
| Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-β | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,015,000 | April 1, 2021 | August 31, 2028 | ROGERS, CLAUDE J. | reporter.nih.gov |
| Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotics LR-IL-22 and LR-IFN-β | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $600,000 | April 1, 2021 | March 31, 2023 | ROGERS, CLAUDE J. | reporter.nih.gov |
| Validation of a microRNA panel to pre-symptomatically predict the risk of radiation-induced fibrosis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $533,384 | September 2, 2025 | August 31, 2030 | ROGERS, CLAUDE J. | reporter.nih.gov |
| Investigation of the mechanisms of H-ARS mitigation by the orally administrated GI-ARS mitigator LR-IFN-beta | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $470,309 | December 17, 2024 | November 30, 2029 | ROGERS, CLAUDE J. | reporter.nih.gov |
| PHASE I AWARD - AN ORGAN-ON-VASCULARNET MODEL FOR IN VITRO EVALUATION OF RADIATION AND DRUG THERAPIES | NIH | National Cancer Institute | 2024 | $399,975 | September 16, 2024 | September 15, 2025 | ROGERS, CLAUDE | reporter.nih.gov |
| CRISPR-based Tropical Infection Diagnostics | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $299,937 | September 15, 2023 | September 14, 2024 | ZHUKOV, DMITRY | reporter.nih.gov |
| Eye-Path Resubmission | NIH | National Eye Institute | 2022 | $299,930 | June 1, 2022 | May 31, 2023 | KYUBWA, ESPOIR | reporter.nih.gov |
| SBIR Topic 134: Alternatives to Benzathine Penicillin for Treatment of Syphilis | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $299,914 | September 25, 2024 | September 24, 2025 | JIMENZ, JORGE | reporter.nih.gov |
| POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $107,961 | March 1, 2017 | February 28, 2023 | MENON, NARESH | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 6 | $5,416,458 | 0 | $0 |
| 2024 | 5 | $3,828,119 | 0 | $0 |
| 2023 | 3 | $2,731,523 | 0 | $0 |
| 2022 | 4 | $2,094,198 | 0 | $0 |
| 2021 | 4 | $2,244,728 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 3 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 3 awards here |
Topics of its NIH awards
- Biotechnology
- Infectious Diseases
- Rare Diseases
- Translational Research
- Physical Injury - Accidents and Adverse Effects
- Bioengineering
- Biodefense and Related Countermeasures
- Complementary and Integrative Health
- Digestive Diseases
- Malaria
- Vector-Borne Diseases
- Genetics
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.